Evidence map›Paper›PMID 33870234›Full record

ArticleJTCVS open2021

Coronary artery bypass graft surgery outcomes in the United States: Impact of the coronavirus disease 2019 (COVID-19) pandemic.

Vibhu Parcha, Rajat Kalra, Austin M Glenn, James E Davies, Seth Kuranz, Garima Arora, Pankaj Arora

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JTCVS open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Complications Associated With Transesophageal Echocardiography in Transcatheter Structural Cardiac Interventions.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2023
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Vibhu ParchaDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Ala.
Rajat KalraCardiovascular Division, University of Minnesota, Minneapolis, Minn.
Austin M GlennSchool of Medicine, University of Alabama at Birmingham, Birmingham, Ala.
James E DaviesDivision of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Ala.
Seth KuranzTriNetX, Inc, Cambridge, Mass.
Garima AroraDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Ala.
Pankaj AroraDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Ala.

Funding

Race, Natriuretic Peptides and Physiological PerturbationsK23HL146887 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ARORA, PANKAJ · 2019 to 2023
$969k
NHLBI NIH HHS K23 HL146887
6 · The paper itself

Abstract

objectiveThere has been a substantial decline in patients presenting for emergent and routine cardiovascular care in the United States after the onset of the coronavirus disease 2019 (COVID-19) pandemic. We sought to assess the risk of adverse clinical outcomes among patients undergoing coronary artery bypass graft (CABG) surgery during the 2020 COVID-19 pandemic period and compare the risks with those undergoing CABG before the pandemic in the year 2019.

methodsA retrospective cross-sectional analysis of the TriNetX Research Network database was performed. Patients undergoing CABG between January 20, 2019, and September 15, 2019, contributed to the 2019 cohort, and those undergoing CABG between January 20, 2020, and September 15, 2020, contributed to the 2020 cohort. Propensity-score matching was performed, and the odds of mortality, acute kidney injury, stroke, acute respiratory distress syndrome, and mechanical ventilation occurring by 30 days were evaluated.

resultsThe number of patients undergoing CABG in 2020 declined by 35.5% from 5534 patients in 2019 to 3569 patients in 2020. After propensity-score matching, 3569 patient pairs were identified in the 2019 and the 2020 cohorts. Compared with those undergoing CABG in 2019, the odds of mortality by 30 days were 0.96 (95% confidence interval [CI], 0.69-1.33;

conclusionsThe number of patients undergoing CABG in 2020 has substantially declined compared with 2019. Similar odds of adverse clinical outcomes were seen among patients undergoing CABG in the setting of COVID-19 compared with those in 2019.

Indexed as

CABG, coronary artery bypass graftingCI, confidence intervalcoronary artery bypass graftcoronary artery diseasecoronavirus disease 2019COVID-19, coronavirus disease 2019EHR, electronic health recordICD-10, International Statistical Classification of Diseases and Related Health Problems, Tenth Revisionmyocardial infarctionOR, odds ratioUAB, University of Alabama at Birmingham

Identifiers

PMID33870234
PMCPMC8007527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.